Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

1 Vanguard ETF That Has Never Let Long-Term Investors Down.: https://g.foolcdn.com/editorial/images/878538/best-etf-to-buy.jpg
1 Vanguard ETF That Has Never Let Long-Term Investors Down.

With recession worries creeping back into the headlines, it's tempting to get clever with your money. Jump in and out, chase hedges, hunt for the one stock that will hold up. Most of the time

Best Restaurant Stock to Buy: Cava Stock vs. Chipotle Stock: https://g.foolcdn.com/editorial/images/878542/mqdefault_custom_2.jpg
Best Restaurant Stock to Buy: Cava Stock vs. Chipotle Stock

The restaurant industry is facing several headwinds.

*Stock prices used were the afternoon prices of July 9, 2026. The video was published on July 11, 2026.

Continue reading

Source Fool.com

Best AI Stock to Buy: Micron Stock vs. AMD Stock: https://g.foolcdn.com/editorial/images/878541/7-amd-vs-micron.jpg
Best AI Stock to Buy: Micron Stock vs. AMD Stock

AMD (NASDAQ: AMD) and Micron (NASDAQ: MU) have excellent growth prospects over the next several years.

*Stock prices used were the afternoon prices of July 9, 2026. The video was published on July

Should You Buy the Dip in Nvidia Stock?: https://g.foolcdn.com/editorial/images/878540/6-nvidia.jpeg
Should You Buy the Dip in Nvidia Stock?

Nvidia's (NASDAQ: NVDA) market price hasn't increased as significantly as some of its peers.

*Stock prices used were the afternoon prices of July 9, 2026. The video was published on July 11, 2026.

Top Value Investor Bill Miller IV Says Bitcoin Is Undervalued. So How Much Higher Can Bitcoin Go This Year?: https://g.foolcdn.com/editorial/images/878023/gold-bitcoin-pile.jpg
Top Value Investor Bill Miller IV Says Bitcoin Is Undervalued. So How Much Higher Can Bitcoin Go This Year?

With Bitcoin (CRYPTO: BTC) down 50% from its all-time highs, the decision to invest in cryptocurrency has become tremendously polarizing. Some investors have already thrown in the towel, convinced

What's Behind a $211,680 CEO Sale at Vicor While AI Demand Drives 20% Revenue Growth?Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
What's Behind a $211,680 CEO Sale at Vicor While AI Demand Drives 20% Revenue Growth?

Patrizio Vinciarelli, the chairman & CEO of Vicor Corporation (NASDAQ:VICR), sold 700 shares of common stock at $302.40 per share for a total value of $211,680 on July 6, 2026, according to an SEC

Is the "Solana Summer" Finally Here?: https://g.foolcdn.com/editorial/images/878330/investor-looks-out-window-while-pondering-and-holding-phone.jpg
Is the "Solana Summer" Finally Here?

Solana (CRYPTO: SOL) just did something it had never done before. In the week ending July 6, it cleared more than 1 billion non-vote transactions, and its count of weekly active wallet addresses

Best Artificial Intelligence (AI) Stock: AMD, Nvidia, or Broadcom: https://g.foolcdn.com/editorial/images/878172/photo-of-data-center-with-gpus.jpg
Best Artificial Intelligence (AI) Stock: AMD, Nvidia, or Broadcom

If you asked me at the start of the year how I would rank Advanced Micro Devices (NASDAQ: AMD), Broadcom (NASDAQ: AVGO), and Nvidia (NASDAQ: NVDA) in terms of potential stock performance, I would

What This Invesco Insider Move Signals With the Stock Up 63%Photo, wide shot, wide-angle lens,  Bank, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/3aa597ca-f944-4a9b-bf8d-3071f3b5a5c9.png
What This Invesco Insider Move Signals With the Stock Up 63%

Jeffrey H. Kupor, a senior managing director of Invesco Ltd. (NYSE:IVZ), executed a non-discretionary disposition of 26,002 shares on July 2, 2026, according to an SEC Form 4 filing.

Transaction

An Astera Labs Insider Sold at $458, but the 93% Revenue Growth Is the Real StoryPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
An Astera Labs Insider Sold at $458, but the 93% Revenue Growth Is the Real Story

Manuel Alba, a Director at Astera Labs, Inc. (NASDAQ:ALAB), executed a sale of 8,491 shares of common stock on July 1, 2026, according to an SEC Form 4 filing.

Transaction value based on SEC Form 4

Jeff Bezos' Blue Origin Raised $10 Billion at a $130 Billion Valuation: https://g.foolcdn.com/editorial/images/878281/gettyimages-1742327158-1.jpg
Jeff Bezos' Blue Origin Raised $10 Billion at a $130 Billion Valuation

Jeff Bezos has bankrolled his rocket company Blue Origin almost single-handedly for a quarter century, quietly selling roughly $1 billion of Amazon (NASDAQ: AMZN) stock a year to keep it flying

An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run
An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run

Harlan S. Robins, the chief scientific officer of Adaptive Biotechnologies Corporation (NASDAQ:ADPT), sold 386,240 shares of common stock at $22.01 per share on July 2, 2026, according to an SEC

Meet the Vanguard ETF That Has Crushed the S&P 500 Over the Last 10 Years: https://g.foolcdn.com/editorial/images/878293/network-data-connection-satellite.jpg
Meet the Vanguard ETF That Has Crushed the S&P 500 Over the Last 10 Years

Over the past century, the S&P 500 has generated an average annual return of around 10%. Over the past decade, however, the Vanguard S&P 500 ETF (NYSEMKT: VOO) has averaged a 15% annual return

Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.: https://g.foolcdn.com/editorial/images/877982/gettyimages-two-people-smile-and-look-at-computer.jpg
Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.

Investors pay careful attention to Ken Griffin's moves for one major reason: The founder of Citadel has an extremely solid track record of success. Citadel, which oversees $69 billion, in January

Is PayPal Stock a Bargain or a Value Trap?: https://g.foolcdn.com/editorial/images/868758/pypl.png
Is PayPal Stock a Bargain or a Value Trap?

PayPal (NASDAQ: PYPL) has been one of the most disappointing stocks over the past five years, losing 85% of its value. It's down another 20% this year.

With the stock trading at a forward

Ultra Clean Insider Sells 3,837 Shares After Q1 Revenue Hit $533.7 Million
Ultra Clean Insider Sells 3,837 Shares After Q1 Revenue Hit $533.7 Million

Brian E. Harding, Chief Accounting Officer of Ultra Clean Holdings, Inc. (NASDAQ:UCTT), sold 3,837 shares of common stock at $128.75 per share on July 2, 2026, according to an SEC Form 4 filing.

Retiring with $1.2 Million? Here's How to Avoid Running Out of Savings: https://g.foolcdn.com/editorial/images/878313/senior-couple-kayak-gettyimages-1452776340.jpg
Retiring with $1.2 Million? Here's How to Avoid Running Out of Savings

As always, The Motley Fool cannot and does not provide personalized investing or financial advice. This information is for informational and educational purposes only and is not a substitute for

What This Immunome Sale Means a Day Before a Big FDA MilestonePhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
What This Immunome Sale Means a Day Before a Big FDA Milestone

Isaac Barchas, a director at Immunome, Inc. (NASDAQ:IMNM), executed a sale of 100,000 shares in a transaction disclosed in a recent SEC Form 4 filing.

Immunome is a clinical-stage biotechnology

Kymera's CEO Sold $6 Million in Stock After a 170% RunPhoto, wide shot, wide-angle lens,  Cable TV provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/51ec7f0d-2b5e-41f6-baa4-43bf0f5d7e7d.png
Kymera's CEO Sold $6 Million in Stock After a 170% Run

Chief Executive Officer Nello Mainolfi sold 50,000 shares of Kymera Therapeutics (NASDAQ:KYMR) on July 7, 2026, for total proceeds of about $6.0 million, according to an SEC Form 4 filing.

Kymera

J.P. Morgan Called a Potential Elon Musk SpaceX-Tesla Merger "Strategically Coherent": https://g.foolcdn.com/editorial/images/878276/handshake-business-deal-merger.jpg
J.P. Morgan Called a Potential Elon Musk SpaceX-Tesla Merger "Strategically Coherent"

Now that Elon Musk's rocket and satellite company Space Exploration Technologies (NASDAQ: SPCX) trades publicly, Wall Street has started hunting for the next best thing: stocks that can ride its

Prediction: SpaceX Shares Can Reach $220 by End of 2026: https://g.foolcdn.com/editorial/images/877861/professional_working_on_a_laptop_in_the_office_late_at_night.jpg
Prediction: SpaceX Shares Can Reach $220 by End of 2026

Space Exploration Technologies (NASDAQ: SPCX) has become one of the market's most closely watched stocks after its rapid entry into the Nasdaq-100 index on July 7. Shares are trading close to $149

Amazon Just Announced Shocking $25 Billion News. Should Investors Worry?: https://g.foolcdn.com/editorial/images/878170/person-looking-at-a-computer-screen-worried.jpg
Amazon Just Announced Shocking $25 Billion News. Should Investors Worry?

Amazon (NASDAQ: AMZN) is reported to have made a shocking decision in recent days. According to CNBC, it is issuing $25 billion in debt to fund its data center build-out. While it doesn't plan to

1 Low-Cost Vanguard ETF Could Turn $300 per Month Into a $1 Million Portfolio. Here's How.: https://g.foolcdn.com/editorial/images/878296/senior-man-and-woman-smiling-and-holding-each-other-in-front-of-a-house-home-couple-30-year-mortgage.jpg
1 Low-Cost Vanguard ETF Could Turn $300 per Month Into a $1 Million Portfolio. Here's How.

It's a dream for most people to earn the title of "millionaire." There's a perception that in order to reach the $1 million mark, you need to either win the lottery or be the beneficiary of a major

What This $1.1 Million Insider Sale at Accelerant Means for InvestorsPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
What This $1.1 Million Insider Sale at Accelerant Means for Investors

Jeffrey L. Radke, Co-Founder and CEO of Accelerant Holdings (NYSE:ARX), sold 80,000 Class A Common Shares on July 6, 2026, for approximately $1.1 million, as disclosed in a recent SEC Form 4 filing.

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between FBT's highly concentrated portfolio and IBB's broader